; and (iii) a neurologic disease with known treatments; and (B) special populations, including— (i) infants and children; (ii) critically ill (non-infectious and non-trauma) patients; (iii) transplant patients; (iv) individuals with cardiac disease; and (v) individuals with, or who have a family history of, a birth defect or developmental disability. (b) Report (1) In general The arrangement under subsection (a) shall provide for the National Academy of Medicine to submit, not later than 3 years after the date of enactment of this Act, a report on the results of the study under subsection (a) to— (A) the Secretary of Health and Human Services; (B) the Committee on Ways and Means and the Committee on Energy and Commerce of the House of Representatives